Easing an episode, or making the next one less likely

Research on episodic conditions usually sets out to answer one of two questions. Some studies look at what shortens or softens an episode once it has begun. Others look at what makes the next one less likely, or milder when it comes.

A nurse preparing medicine at a clinic bench

Three things to take away

  • Some studies look at shortening or easing an episode once it has begun.
  • Others look at making the next episode less likely, or milder when it arrives.
  • Talk to your own doctor before any change to a treatment you already use.

Stopping an attack versus spacing attacks out

While an episode is under way, the question is how to bring it to an end sooner or make it easier to get through. Between episodes, the question turns to prevention: whether something used every day can push attacks further apart. These are separate lines of research, and a study is usually built around one of them.

Which question a study picks changes the tasks it sets you. A study about easing attacks needs to know when each one started and how it changed after a treatment was used. A study about prevention cares more about how many episodes you have across several months and how much they get in the way of your days.

Research aimed at the attack in progress

In Ménière’s disease, research has looked at ways to calm a vertigo attack and the sickness that comes with it once the spinning has started. In atrial fibrillation, some studies look at ways to bring the heart back to a steady rhythm sooner once an episode begins.

Studies like these often ask you to note when an episode started, when you used the study treatment and when you began to feel better. Some ask you to rate how you feel at set points during the attack. The aim is a clear account of how the episode ran, from the first sign to the moment it settled.

Research aimed at the attack still to come

Prevention studies look at the weeks between attacks. In recurrent pericarditis, research asks how to keep inflammation from coming back once the chest pain has eased. In chronic hives, studies ask whether a daily treatment keeps new welts from forming over months. In trigeminal neuralgia and Ménière’s disease, they look at ways to make attacks rarer or gentler, including approaches meant to protect hearing and balance.

Because prevention is measured by what does not happen, these studies tend to run longer. Researchers compare how often episodes arrived before and during the study, and whether those that still came were shorter or milder. A single quiet month counts for little, so the comparison usually spans a long stretch.

Studies that ask both questions together

Some research looks at both at once. A POTS study might ask whether a daily approach cuts the number of dizzy spells on standing, and also whether the spells that remain pass more quickly. A study team can tell you which question it is asking, and the answer says a lot about what taking part would involve.

Whatever a study looks at, you keep using your usual treatment unless your own doctor agrees to a change. Never stop or adjust a medicine because of something you read about research. If a study interests you, take its details to your doctor and ask how it would sit alongside the care you already have.

More guides

All six guides

Read first, then decide

Tell Patient Charter your ZIP code and the condition you follow, and an occasional note about nearby research will follow.

Get updates